US court reverses $482 million case against JNJ's Cordis
WASHINGTON, April 4
WASHINGTON, April 4 (Reuters) - Cordis Corp, a Johnson and Johnson subsidiary, did not infringe upon a stent patent owned by a radiologist, an appeals court said on Thursday, reversing a ruling by a lower court which had ordered Cordis to pay $482 million.
The U.S. Court of Appeals for the Federal Circuit reversed a ruling from a Texas jury, which had found Cordis guilty of infringement and ordered the payment, plus interest.
The appeals court ruled that Cordis had not infringed.
A lawyer for the radiologist, Bruce Saffran, was not immediately available.
The case in the U.S. District Court for the Eastern District of Texas was No. 07-CV-0451. The case at the U.S. Court of Appeals for the Federal Circuit is Bruce Saffran v. Johnson & Johnson and Cordis Corp., No. 2012-1043.
- Alabama man gets $1,000 in police settlement, his lawyers get $459,000
- Probe: Athletes took fake classes at University of North Carolina
- Ottawa pushes for business as usual after shootings |
- Man arrested after jumping White House fence, causing lockdown
- U.S.-led air strikes killed 521 fighters, 32 civilians in Syria: monitor